Janiak P - Search Results

1

Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor.

Löhn M, Plettenburg O, Ivashchenko Y, Kannt A, Hofmeister A, Kadereit D, Schaefer M, Linz W, Kohlmann M, Herbert JM, Janiak P, O'Connor SE, Ruetten H. Löhn M, et al. Among authors: janiak p. Hypertension. 2009 Sep;54(3):676-83. doi: 10.1161/HYPERTENSIONAHA.109.134353. Epub 2009 Jul 13. Hypertension. 2009. PMID: 19597037

2

SSR69071, an elastase inhibitor, reduces myocardial infarct size following ischemia-reperfusion injury.

Bidouard JP, Duval N, Kapui Z, Herbert JM, O'Connor SE, Janiak P. Bidouard JP, et al. Among authors: janiak p. Eur J Pharmacol. 2003 Feb 7;461(1):49-52. doi: 10.1016/s0014-2999(03)01298-6. Eur J Pharmacol. 2003. PMID: 12568915

3

Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion.

Leducq N, Bono F, Sulpice T, Vin V, Janiak P, Fur GL, O'Connor SE, Herbert JM. Leducq N, et al. Among authors: janiak p. J Pharmacol Exp Ther. 2003 Sep;306(3):828-37. doi: 10.1124/jpet.103.052068. J Pharmacol Exp Ther. 2003. PMID: 12928523

4

Serotonin aggravates exercise-induced cardiac ischemia in the dog: effect of serotonin receptor antagonists.

Guilbert F, Lainée P, Dubreuil B, McCort G, O'Connor SE, Janiak P, Herbert JM. Guilbert F, et al. Among authors: janiak p. Eur J Pharmacol. 2004 Aug 16;497(1):55-63. doi: 10.1016/j.ejphar.2004.06.024. Eur J Pharmacol. 2004. PMID: 15321735

5

Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger.

Lorrain J, Briand V, Favennec E, Duval N, Grosset A, Janiak P, Hoornaert C, Cremer G, Latham C, O'Connor SE. Lorrain J, et al. Among authors: janiak p. Br J Pharmacol. 2000 Nov;131(6):1188-94. doi: 10.1038/sj.bjp.0703671. Br J Pharmacol. 2000. PMID: 11082127 Free PMC article.

6

Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats.

Janiak P, Bidouard JP, Cadrouvele C, Poirier B, Gouraud L, Grataloup Y, Pierre F, Bruneval P, O'Connor SE, Herbert JM. Janiak P, et al. Eur J Pharmacol. 2006 Mar 18;534(1-3):271-9. doi: 10.1016/j.ejphar.2006.01.032. Epub 2006 Mar 6. Eur J Pharmacol. 2006. PMID: 16516882

7

A G protein-biased S1P₁ agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers.

Poirier B, Briand V, Kadereit D, Schäfer M, Wohlfart P, Philippo MC, Caillaud D, Gouraud L, Grailhe P, Bidouard JP, Trellu M, Muslin AJ, Janiak P, Parkar AA. Poirier B, et al. Among authors: janiak p. Sci Signal. 2020 Jun 2;13(634):eaax8050. doi: 10.1126/scisignal.aax8050. Sci Signal. 2020. PMID: 32487716

8

Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.

Berry CN, Lorrain J, Lochot S, Delahaye M, Lalé A, Savi P, Lechaire I, Ferrari P, Bernat A, Schaeffer P, Janiak P, Duval N, Grosset A, Herbert JM, O'Connor SE. Berry CN, et al. Among authors: janiak p. Thromb Haemost. 2001 Mar;85(3):521-8. Thromb Haemost. 2001. PMID: 11307825

9

Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.

O'Connor SE, Grosset A, La Rochelle CD, Gautier E, Bidouard JP, Robineau P, Caille D, Janiak P. O'Connor SE, et al. Among authors: janiak p. Eur J Pharmacol. 2001 Mar 2;414(2-3):259-69. doi: 10.1016/s0014-2999(01)00804-4. Eur J Pharmacol. 2001. PMID: 11239927

10

SL65.0472 blocks 5-hydroxytryptamine-induced vasoconstriction in a dog hindlimb ischemia model.

Barbe F, Gautier E, Bidouard JP, Grosset A, O'Connor SE, Janiak P. Barbe F, et al. Among authors: janiak p. Eur J Pharmacol. 2003 Aug 1;474(1):117-20. doi: 10.1016/s0014-2999(03)02032-6. Eur J Pharmacol. 2003. PMID: 12909202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters